Ind-Swift Ltd
INDSWFTLTD
Company Profile
Business description
Ind-Swift Ltd is an India-based pharmaceutical company. It engages in the manufacturing and marketing of pharmaceutical products. The company's products are classified into divisions namely, Generic Division, NOVA Division, Ethical Division, Nobel Division, Herba Plus Division, Institution Division, and Proposed Division. The manufacturing facilities of the firm are situated in (Derabassi)Punjab, India. Substantial revenue accrues from export sales of products.
Contact
781, Industrial Area
Phase II
Chandigarh160002
INDT: +91 1722638781
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
1,054
Stocks News & Analysis
stocks
Better times ahead for these cheap ASX shares?
Our analysts think the outlook looks fairly good for these two undervalued and unloved ASX dividend payers.
video
ASX dividend stocks for 2025
With dividend yields at 25-year lows, it's time to rethink ASX stocks for income according to James Gruber.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,699.10 | 57.60 | -0.66% |
| CAC 40 | 8,120.41 | 86.15 | -1.05% |
| DAX 40 | 22,500.17 | 344.33 | -1.51% |
| Dow JONES (US) | 44,436.70 | 119.64 | -0.27% |
| FTSE 100 | 8,721.86 | 44.87 | -0.51% |
| HKSE | 22,944.24 | 32.57 | -0.14% |
| NASDAQ | 19,976.76 | 64.50 | -0.32% |
| Nikkei 225 | 39,164.61 | 105.79 | -0.27% |
| NZX 50 Index | 13,033.36 | 17.76 | -0.14% |
| S&P 500 | 6,120.68 | 8.90 | -0.15% |
| S&P/ASX 200 | 8,419.20 | 61.80 | -0.73% |
| SSE Composite Index | 3,351.54 | 27.05 | 0.81% |